Grass Pollen Rhinoconjunctivitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2009-11-13
Clinical Trial Update: Immunomodulation of E.Coli Nissle 1917 in Patients With Grass Pollen Rhinoconjunctivitis [Phase 2]
Phase 2 trial evaluating immunomodulation with Escherichia coli Nissle 1917 in grass pollen rhinoconjunctivitis has completed.